Maze Therapeutics: HC Wainwright Raises PT to $110, Maintains Buy Rating

miércoles, 25 de marzo de 2026, 11:20 am ET1 min de lectura
MAZE--

Maze Therapeutics: HC Wainwright Raises PT to $110, Maintains Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios